je.st
news
Stanford stem cell product, delayed for more than a decade, to be tested again
2015-06-14 02:10:05| Biotech - Topix.net
In the 1990s, Stanford's Irv Weissman created a unique way to grow and deliver blood stem cells to desperate patients with aggressive cancers, boosting survival rates. But then the discovery itself died -- a victim of the heartbreaking economics of commercial stem-cell development, where the long and rocky road of research, especially in the field of "personalized medicine," often discourages investment.
Tags: to
product
again
cell
Category:Biotechnology and Pharmaceuticals